Share-based Payment Arrangement, Expense of UTAH MEDICAL PRODUCTS INC from 31 Dec 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
UTAH MEDICAL PRODUCTS INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 31 Dec 2024.
  • UTAH MEDICAL PRODUCTS INC Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2024 was $71,000, a 1.4% decline year-over-year.
  • UTAH MEDICAL PRODUCTS INC Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2024 was $255,000, a 13% increase year-over-year.
  • UTAH MEDICAL PRODUCTS INC annual Share-based Payment Arrangement, Expense for 2024 was $255,000, a 13% increase from 2023.
  • UTAH MEDICAL PRODUCTS INC annual Share-based Payment Arrangement, Expense for 2023 was $225,000, a 23% increase from 2022.
  • UTAH MEDICAL PRODUCTS INC annual Share-based Payment Arrangement, Expense for 2022 was $183,000, a 10% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

UTAH MEDICAL PRODUCTS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $255,000 $71,000 -$1,000 -1.4% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
Q3 2024 $256,000 $53,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $256,000 $52,000 +$2,000 +4% 01 Apr 2024 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $254,000 $79,000 +$29,000 +58% 01 Jan 2024 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $225,000 $72,000 +$10,000 +16% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 $215,000 $53,000 +$15,000 +39% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $200,000 $50,000 +$10,000 +25% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $190,000 $50,000 +$7,000 +16% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $183,000 $62,000 +$19,000 +44% 01 Oct 2022 31 Dec 2022 10-K 26 Mar 2025 2024 FY
Q3 2022 $164,000 $38,000 -$3,000 -7.3% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $167,000 $40,000 -$1,000 -2.4% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $168,000 $43,000 +$2,000 +4.9% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 $166,000 $43,000 +$4,000 +10% 01 Oct 2021 31 Dec 2021 10-K 26 Mar 2024 2023 FY
Q3 2021 $162,000 $41,000 -$8,000 -16% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $170,000 $41,000 -$8,000 -16% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 $178,000 $41,000 +$18,000 +78% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q4 2020 $160,000 $39,000 +$11,000 +39% 01 Oct 2020 31 Dec 2020 10-K/A 28 Mar 2023 2022 FY
Q3 2020 $149,000 $49,000 +$20,000 +69% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $129,000 $49,000 +$21,000 +75% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021 2021 Q2
Q1 2020 $108,000 $23,000 -$5,000 -18% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q4 2019 $113,000 $28,000 +$34,000 01 Oct 2019 31 Dec 2019 10-K 25 Mar 2022 2021 FY
Q3 2019 $79,000 $29,000 $0 0% 01 Jul 2019 30 Sep 2019 10-Q/A 09 Nov 2020 2020 Q3
Q2 2019 $79,000 $28,000 +$17,000 +155% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2019 $62,000 $28,000 -$2,000 -6.7% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $64,000 $6,000 -$36,000 -120% 01 Oct 2018 31 Dec 2018 10-K 26 Mar 2021 2020 FY
Q3 2018 $100,000 $29,000 -$1,000 -3.3% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2020 2020 Q3
Q2 2018 $101,000 $11,000 -$22,000 -67% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $123,000 $30,000 -$6,000 -17% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $129,000 $30,000 $0 0% 01 Oct 2017 31 Dec 2017 10-K 16 Mar 2020 2019 FY
Q3 2017 $129,000 $30,000 +$10,000 +50% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $119,000 $33,000 +$12,000 +57% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $107,000 $36,000 +$15,000 +71% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q4 2016 $92,000 $30,000 +$9,000 +43% 01 Oct 2016 31 Dec 2016 10-K 14 Mar 2019 2018 FY
Q3 2016 $83,000 $20,000 -$2,000 -9.1% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $85,000 $21,000 -$1,000 -4.5% 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017 2017 Q2
Q1 2016 $86,000 $21,000 -$1,000 -4.5% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q4 2015 $87,000 $21,000 +$8,000 +62% 01 Oct 2015 31 Dec 2015 10-K 06 Mar 2018 2017 FY
Q3 2015 $79,000 $22,000 -$3,000 -12% 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016 2016 Q3
Q2 2015 $82,000 $22,000 +$4,000 +22% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2
Q1 2015 $78,000 $22,000 +$4,000 +22% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1
Q4 2014 $74,000 $13,000 +$6,000 +86% 01 Oct 2014 31 Dec 2014 10-K 08 Mar 2017 2016 FY
Q3 2014 $68,000 $25,000 +$18,000 +257% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015 2015 Q3
Q2 2014 $50,000 $18,000 +$11,000 +157% 01 Apr 2014 30 Jun 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 $39,000 $18,000 +$11,000 +157% 01 Jan 2014 31 Mar 2014 10-Q 07 Aug 2015 2015 Q2
Q4 2013 $28,000 $7,000 -$9,000 -56% 01 Oct 2013 31 Dec 2013 10-K 10 Mar 2016 2015 FY
Q3 2013 $37,000 $7,000 -$9,000 -56% 01 Jul 2013 30 Sep 2013 10-Q 04 Nov 2014 2014 Q3
Q2 2013 $46,000 $7,000 -$11,000 -61% 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2014 2014 Q2
Q1 2013 $57,000 $7,000 -$13,000 -65% 01 Jan 2013 31 Mar 2013 10-Q 07 May 2014 2014 Q1
Q4 2012 $70,000 $16,000 01 Oct 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY
Q3 2012 $16,000 -$8,000 -33% 01 Jul 2012 30 Sep 2012 10-Q 06 Nov 2013 2013 Q3
Q2 2012 $18,000 -$7,000 -28% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013 2013 Q2
Q1 2012 $20,000 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013 2013 Q1
Q3 2011 $24,000 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012 2012 Q3
Q2 2011 $25,000 01 Apr 2011 30 Jun 2011 10-Q 08 Aug 2012 2012 Q2

UTAH MEDICAL PRODUCTS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $255,000 +$30,000 +13% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
2023 $225,000 +$42,000 +23% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
2022 $183,000 +$17,000 +10% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2025 2024 FY
2021 $166,000 +$6,000 +3.8% 01 Jan 2021 31 Dec 2021 10-K 26 Mar 2024 2023 FY
2020 $160,000 +$47,000 +42% 01 Jan 2020 31 Dec 2020 10-K/A 28 Mar 2023 2022 FY
2019 $113,000 +$49,000 +77% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2022 2021 FY
2018 $64,000 -$65,000 -50% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2021 2020 FY
2017 $129,000 +$37,000 +40% 01 Jan 2017 31 Dec 2017 10-K 16 Mar 2020 2019 FY
2016 $92,000 +$5,000 +5.7% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019 2018 FY
2015 $87,000 +$13,000 +18% 01 Jan 2015 31 Dec 2015 10-K 06 Mar 2018 2017 FY
2014 $74,000 +$46,000 +164% 01 Jan 2014 31 Dec 2014 10-K 08 Mar 2017 2016 FY
2013 $28,000 -$42,000 -60% 01 Jan 2013 31 Dec 2013 10-K 10 Mar 2016 2015 FY
2012 $70,000 -$25,000 -26% 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY
2011 $95,000 +$12,000 +14% 01 Jan 2011 31 Dec 2011 10-K 12 Mar 2014 2013 FY
2010 $83,000 01 Jan 2010 31 Dec 2010 10-K 07 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.